The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies
1 other identifier
observational
100
1 country
1
Brief Summary
The telomere system stabilizes the chromosomes. Telomeres are shortened during senescence, in cases of genetic instability and secondary to stress. The investigators aim is to study the telomere system in cord blood and in the placenta immediately after the delivery in pregnancies defined as high risk pregnancies following sterss events such as placental insufficiency, preeclampsia, diabetes. The investigators intend to compare the telomere system in maternal blood to cord blood and to placental biopsies and to study the influence of different stressogenes on this system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 27, 2011
CompletedFirst Posted
Study publicly available on registry
June 28, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedJune 28, 2011
June 1, 2011
4 years
June 27, 2011
June 27, 2011
Conditions
Study Arms (2)
High risk pregnancy
|Control - Normal low risk pregnancies
Eligibility Criteria
High risk pregnancies, third trimester, after the delivery/
You may qualify if:
- Third trimester post delivery
- Intrauterine growth restriction
- Preeclampsia
- Diabetes
- Control - low risk normal pregnancies
You may not qualify if:
- Patients who do not want to participate
- Known HIV or Hepatitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meir Medical Center
Kfar Saba, Israel
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 27, 2011
First Posted
June 28, 2011
Study Start
June 1, 2011
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
June 28, 2011
Record last verified: 2011-06